Sequence
CJC-1295 (no DAC)
Modified GRF (1–29): a 29-residue GHRH(1–29) analogue with four substitutions.
- Full identity data listed below
- Cold-packed, discreet, tracked
- Replace or refund if damaged, wrong or not as described
For in-vitro research only. Not a drug, food, supplement or cosmetic, and not for human or veterinary use. Chainwell provides no dosing or usage guidance.
- Sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol
- Form
- Lyophilized powder
- Purity
- ≥ 98% · supplier specification
Synthetic 29-residue analogue of human GHRH(1–29) with D-Ala2, Gln8, Ala15 and Leu27 substitutions and a C-terminal amide. Also listed as Modified GRF 1-29. Supplied as a lyophilized powder for in-vitro laboratory research.
The purity shown is the supplier's specification. We haven't started independent lot testing yet.
Independent third-party testing is on our roadmap. When it starts, every lot's report will be published here.
Store at −20 °C, protected from light. Ships with cold packs. Handle according to good laboratory practice. A safety data sheet is available on request.